3D-QSAR study of combretastatin a-4 analogs based on molecular docking

Molecules

Volumn 16, Issue 8, 2011, Pages 6684-6700

  Jin, Yinghua ^a   Qi, Ping ^a,b   Wang, Zhiwei ^b   Shen, Qirong ^b   Wang, Jian ^b   Zhang, Weige ^b   Song, Hongrui ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Antitumoral and antivascular activities; CA 4; CoMFA; Dock

Indexed keywords

AMINO ACID; COLCHICINE; COMBRETASTATIN A4 PHOSPHATE; PRODRUG; STILBENE DERIVATIVE; TUBULIN;

CHEMISTRY; ENZYME ACTIVE SITE; METABOLISM; MOLECULAR DOCKING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REPRODUCIBILITY;

AMINO ACIDS; CATALYTIC DOMAIN; COLCHICINE; MOLECULAR DOCKING SIMULATION; PRODRUGS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REPRODUCIBILITY OF RESULTS; STILBENES; TUBULIN;

EID: 80052244297     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16086684     Document Type: Article

References (43)

1. Pettit, G.R.; Singh, S.B.; Hamel, E.; Lin, C.M.; Alberts, D.S.; Garcia-Kendall, D. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4. Experientia 1989, 45, 209-211. (Pubitemid 19062390)
2. Lin, C.M.; Singh, S.R.; Chu, P.S.; Dempcy, R.O.; Schmidt, J.M.; Pettit, G.R.; Hamel, E. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: A structure-activity study. Mol. Phamacol. 1988, 34, 200-208.
3. Pettit, G.R.; Singh, S.G.; Boyd, M.R.; Hamel, E.; Pettit, R.K.; Schmidt, J.M.; Hogan, F. Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6. J. Med. Chem. 1995, 38, 1666-1672.
4. Patterson, D.M.; Rustin, G.J.S. Combretastatin A-4 phosphate. Drugs Future 2007, 32, 1025-1032.
5. Lippert, J.W. Vascular disrupting agents. Bioorg. Med. Chem. 2007, 15, 605-615.
6. Liao, S.Y.; Chen, J.C.; Miao, T.F.; Shen, Y.; Zheng, K.C. Binding conformations and QSAR of CA-4 analogs as tubulin inhibitors. J. Enzyme Inhib. Med. Chem. 2010, 25, 421-429.
7. Ji, Y.B.; Tian, R.; Lin, W.H. QSAR and molecular docking study of a series of combretastatin analogues tubulin inhibitors. Lect. Notes. Comput. Sci. 2007, 4689, 436-444.
8. Flynn, B.L.; Flynn, G.P.; Hamel, E.; Jung, M.K. The synthesis and tubulin binding activity of thiophene-based analogues of combretastatin A-4. Bioorg. Med. Chem. Lett. 2001, 11, 2341-2343. (Pubitemid 32781695)
9. Mousset, C.; Giraud, A.; Provot, O.; Hamzé, A.; Bignon, J.; Jian, M.L.; Thoret, S.; Dubois, J.; Brion, J.D.; Alami, M. Synthesis and antitumor activity of benzils related to combretastatin A-4. Bioorg. Med. Chem. Lett. 2008, 18, 3266-3271. (Pubitemid 351728092)
10. Cushman, M.; Nagarathnam, D.; Gopal, D.; Chakraborti, A.K.; Lin, C.M.; Hamel, E. Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization. J. Med. Chem. 1991, 34, 2579-2588.
11. Shirai, R.; Tokuda, K.; Koiso, Y.; Iwasaki, S. Synthesis and anti-tubulin activity of Aza-combretastatins. Bioorg. Med. Chem. Lett. 1994, 4, 699-704. (Pubitemid 24101763)
12. Simoni, D.; Romagnoli, R.; Baruchello, R.; Rondanin, R.; Grisolia, G.; Eleopra, M; Rizzi, M.; Tolomeo, M.; Giannini, G.; Alloatti, D.; et al. Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity. J. Med. Chem. 2008, 51, 6211-6215.
13. Alloatti, D.; Giannini, G.; Cabri, W.; Lustrati, I.; Marzi, M.; Ciacci, A.; Gallo, G.; Tinti, M.O.; Marcellini, M.; Riccioni, T.; et al. Synthesis and biological activity of fluorinated combretastatin analogues. J. Med. Chem. 2008, 51, 2708-2721. (Pubitemid 351620793)
14. Lin, C.M.; Singh, S.B.; Chu, P.S.; Dempcy, R.O.; Schmidt, J.M.; Pettit, G.R.; Hamel, E. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: A structure-activity study. Mol. Pharmacol. 1988, 34, 200-208.
15. Pettit, G.R.; Minardi, M.D.; Rosenberg, H.J.; Hamel, E.; Bibby, M.C.; Martin, S.W.; Jung, M.K.; Pettit, R.K.; Cuthbertson, T.J.; Chapuis, J.C. Antineoplastic agents. 509. Synthesis of fluorcombstatin phosphate and related 3-Halostilbenes. J. Nat Prod. 2005, 68, 1450-1458. (Pubitemid 41658893)
16. Monk, K.A.; Siles, R.; Hadimani, M.B.; Mugabe, B.E.; Freeland, A.J.; Studerus, S.W.; Edvardsen, K.; Trawick, M.L.; Garner, C.M.; Rhodes, M.R.; et al. Design, synthesis and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents. Bioorg. Med. Chem. 2006, 14, 3231-3244.
17. Ohsumi, K.; Nakagawa, R.; Fukuda, Y.; Hatanaka, T.; Morinaga, Y.; Nihei, Y.; Ohishi, K.; Suga, Y.; Akiyama, Y.; Tsuji, T. Novel combretastatin analogues effective against murine solid tumors: Design and structure-activity relationships. J. Med. Chem. 1998, 41, 3022-3032. (Pubitemid 28359938)
18. Hatanaka, T.; Fujita, K.; Ohsumi, K.; Nakagawa, R.; Fukuda, Y.; Nihei, Y.; Suga, Y.; Akiyama, Y.; Tsuji, T. Novel B-ring modifield combretastatin analogues: Synthesis and antineoplastic activity. Bioorg. Med. Chem. Lett. 1998, 8, 3371-3374. (Pubitemid 28547074)
19. Flynn, B.L.; Flynn, G.P.; Hamelb, E.; Jungc, M.K. The synthesis and tubulin binding activity of thiophene-based analogues of combretastatin A-4. Bioorg. Med. Chem. Lett. 2001, 11, 2341-2343. (Pubitemid 32781695)
20. Chang, J.Y.; Yang, M.F.; Chang, C.Y.; Chen, C.M.; Kuo, C.C.; Liou, J.P. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents. J. Med. Chem. 2006, 49, 6412-6415.
21. Gurjar, M.K.; Wakharkar, R.D.; Singh, A.T.; Jaggi, M.; Borate, H.B.; Shinde, P.D.; Verma, R.; Rajendran, P.; Dutt, S.; Singh, G.; et al. Synthesis and evaluation of 4/5-Hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents. J. Med. Chem. 2007, 50, 1744-1753. (Pubitemid 46626586)
22. Cushman, M.; Nagarathnam, D.; Gopal, D.; He, H.M.; Lin, C.M.; Hamel, E. Synthesis and evaluation of analogs of (Z)-1-(4-methoxyphenyl)-2-(3,4,5- trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents. J. Med. Chem. 1992, 35, 2293-2306.
23. Wang, L.; Woods, K.W.; Li, Q.; Barr, K.J.; McCroskey, R.W.; Hannick, S.M.; Gherke, L.; Credo, R.B.; Hui, Y.H.; Marsh, K.; et al. Potent, orally active heterocycle-based combretastatin A-4 analogues: Synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluation. J. Med. Chem. 2002, 45, 1697-1711. (Pubitemid 34293536)
24. Pettit, G.R.; Grealish, M.P.; Jung, M.K.; Hamel, E.; Pettit, R.K.; Chapuis, J.C.; Schmidt, J.M. Antineoplastic agents. 465. Structural modification of resveratrol: Sodium resverastatin phosphate. J. Med. Chem. 2002, 45, 2534-2542. (Pubitemid 34595223)
25. Pettit, G.R.; Anderson, C.R.; Herald, D.L.; Jung, M.K.; Lee, D.J.; Hamel, E.; Pettit, R.K. Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'- amino-Z-stilbene and derived amino acid amides. J. Med. Chem. 2003, 46, 525-531. (Pubitemid 36182754)
26. Maya, A.B.S.; Pérez-Melero, C.; Mateo, C.; Alonso, D.; Fernndez, J.L.; Gajate, C.; Mollinedo, F.; Peláez, R.; Caballero, E.; Medarde, M. Further naphthyl combretastatins. An investigation on the role of the naphthalene moiety. J. Med. Chem. 2005, 48, 556-568. (Pubitemid 40139798)
27. Pettit, G.R.; Rhodes, M.R.; Herald, D.L.; Hamel, E.; Schmidt, J.M.; Pettit, R.K. Antineoplastic Agents. 445. Synthesis and Evaluation of Structural Modifications of (Z)-and (E)-Combretastatin A-4. J. Med. Chem. 2005, 48, 4087-4099. (Pubitemid 40800617)
28. Ohsumi, K.; Nakagawa, R.; Fukuda, Y.; Hatanaka, T.; Morinaga, Y.; Nihei, Y.; Ohishi, K.; Suga, Y.; Akiyama, Y.; Tsuji, T. Novel combretastatin analogues effective against murine solid tumors: Design and structure-activity relationships. J. Med. Chem. 1998, 41, 3022-3032.
29. Kaffy, J.; Pontikis, R.; Carrez, D.; Croisy, A.; Monneret, C.; Florent, J.C. Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation. Bioorg. Med. Chem. 2006, 14, 4067-4077.
30. Simoni, D.; Romagnoli, R.; Baruchello, R.; Rondanin, R.; Rizzi, M.; Pavani, M.G.; Alloatti, D.; Giannini, G.; Marcellini, M.; Riccioni, T.; et al. Novel combretastatin analogues endowed with antitumor activity. J. Med. Chem. 2006, 49, 3143-3152. (Pubitemid 43830513)
31. Thomsen, R.; Christensen, M.H. MolDock: A new technique for high-accuracy molecular docking. J. Med. Chem. 2006, 49, 3315-3321. (Pubitemid 43830529)
32. SYBYL. Molecular Modelling System, version 6.9.1; Tripos Inc.: Saint-Louis, MS, USA, 2003.
33. Teixeira, C.; Serradji, N.; Maurel, F.; Barbault, F. Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors. Eur. J. Med. Chem. 2009, 44, 3524-3532.
34. Lu, P.; Xia, W.; Zhang, R. CoMFA and CoMSIA 3D-QSAR Studies on quionolonecaroxylic acid derivatives inhibitors of HIV-1 integrase. Eur. J. Med. Chem. 2010, 45, 1-7.
35. Wang, R.; Gao, Y.; Liu, L.; Lai, L. All-orientation search and all-placement search in comparative molecular field analysis. J. Mol. Model. 1998, 4, 276-283.
36. Ravelli, R.B.G.; Gigant, B.; Curmi, P.A.; Jourdain, I.; Lachkar, S.; Sobel, A.; Knossow, M. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature 2004, 428, 198-202. (Pubitemid 38374318)
37. He, Y.Z.; Li, Y.X.; Zhu, X.L.; Zhen, X.; Niu, C.W.; Wan, J.; Zhang, L.; Yang, G.F. Rational design based on bioactive conformation analysis of pyrimidinyl benzoates as acetohydroxy acid synthase inhibitors by integrating molecular docking, CoMFA, CoMSIA, and DFT calculations. J. Chem. Inf. Model 2007, 47, 2335-2344. (Pubitemid 350275099)
38. Böhm, H.J.; Stahl, M. Reviews in Computational Chemistry; Lipkowsky, K.B., Boyd, D.B., Eds.; John Wiley & Sons: Hoboken, NJ, USA, 2002; pp. 41-87.
39. Liao, S.Y.; Chen, J.C.; Miao, T.F.; Shen, Y.; Zheng, K.C. Binding conformations and QSAR of CA-4 analogs as tubulin inhibitors. J. Enzyme Inhib. Med. Chem. 2010, 25, 421-429.
40. Hu, R.; Barbault, F.; Delamar, M.; Zhang, R. Receptor- and ligand-based 3D-QSAR study for a series of non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorg. Med. Chem. 2009, 17, 2400-2409.
41. Hu, R.J.; Barbault, F.; Maurel, F.; Delamar, M.; Zhang, R.S. Molecular dynamics simulations of 2-Amino-6-arylsulphonylbenzonitriles analogues as HIV inhibitors: Interaction modes and binding free energies. Chem. Biol. Drug Des. 2010, 76, 518-526.
42. Qiong, X.X.; Mei, D.Z.; Fei, P.B.; Yang, L.; Hong, J.R.; Jian, W.; Sheng, M.C. CoMFA, CoMSIA and eigenvalue analysis on dibenzodioxepinone and dibenzodioxocinone derivatives as cholesteryl ester transfer protein inhibitors. Molecules 2008, 13, 1822-1839.
43. 2. J. Mol. Graph. Model. 2002, 20, 269-276.